Skip to main content

Table 4 The associations between urinary DON levels (ng/mL) and birth outcomes among pregnant women with available dietary data (n = 712)

From: Adverse associations between maternal deoxynivalenol exposure and birth outcomes: a prospective cohort study in China

 

Birth weight (g)

Birth length (cm)

Small for gestational age

β (95%CI)

β (95%CI)

Case (%)

OR (95%CI)

Total DON

 Ln-tDON

-28.78 (-50.59, -6.97)

-0.05 (-0.13, 0.03)

66 (9.27)

1.12 (0.90, 1.39)

 T1

ref

ref

21 (8.50)

ref

 T2

6.10 (-57.26, 69.43)

0.16 (-0.08, 0.40)

18 (7.17)

0.89 (0.45, 1.75)

 T3

-96.50 (-163.04, -29.96)

-0.26 (-0.51, -0.01)

27 (12.62)

1.67 (0.89, 3.14)

 P for trend

0.002

0.011

 

0.061

Free DON

 Ln-fDON

-15.83 (-33.14, 1.48)

-0.05 (-0.12, 0.01)

66 (9.27)

1.04 (0.88, 1.23)

 T1

ref

ref

23 (9.58)

ref

 T2

-5.84 (-58.33,70.01)

-0.05 (-0.30, 0.19)

18 (7.09)

0.73 (0.38, 1.43)

 T3

-68.87 (-135.71, -2.03)

-0.21 (-0.46, 0.05)

25 (11.47)

1.27 (0.68, 2.37)

P for trend

0.021

0.096

 

0.254

  1. Abbreviations: DON deoxynivalenol, fDON free DON, tDON total DON, OR odds ratio, CI confidence interval
  2. Adjusted Model: adjusted for age, pre-pregnancy BMI, weight, average personal income, education attainment, parity, abnormal pregnancy-labor history, morning sickness, alcohol intake, smoking, season of sample collection, infant sex, gestational age at delivery, and cereal intake